Market Overview:
The global poloxamer 184 market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in the market can be attributed to the increasing demand for dermatology and human pharmaceutical applications, and rising awareness about veterinary health applications of poloxamer 184. North America is expected to dominate the global poloxamer 184 market during the forecast period, followed by Europe and Asia Pacific.
Product Definition:
Poloxamer 184 is a non-ionic surfactant and emulsifier. It is used as an excipient in pharmaceuticals, cosmetics, and foods.
Liquid:
Liquid is a colorless, odorless, tasteless liquid. It has viscosity similar to water and isopropyl alcohol. Liquid poloxamer 184 can be used as an alternative to hydroxypropyl methyl cellulose in various applications such as pharmaceuticals and cosmetics.
Poloxamer 184 market demand is expected to grow on account of increasing application scope in the cosmetic industry owing to its ability of being mixed with water, oil & waxes.
Liquid Gel:
Liquid gels are transparent, water-soluble polymers in the form of a liquid. They are extensively used as an injectable drug carrier owing to their unique physical properties such as high viscosity and gel strength. These properties allow them to be used in various pharmaceutical applications including controlled release dosage formulations, sustained release formulations and reformulation of existing drugs into new ones with improved pharmacological profiles.
Application Insights:
The global poloxamer 184 market is segmented by application into dermatology, human pharmaceutical and veterinary health. The dermatology segment dominated the overall market in terms of revenue share in 2017. This can be attributed to the high usage of poloxamers for treating various skin conditions, such as acne vulgaris, psoriasis and eczema. Furthermore, increasing demand for non-invasive procedures that do not require surgery is expected to boost product demand over the forecast period.
Poloxamers are used as excipients in drug delivery systems for humans and animals due to their biodegradable nature which helps reduce environmental pollution caused due to disposal of packaging materials made from non-biodegradable plastics such as polyethylene terephthalate (PET) or polycarbonate (PC).
Regional Analysis:
North America dominated the global poloxamer 184 market in 2017. The region is expected to maintain its position during the forecast period owing to increasing R&D activities and presence of key manufacturers. In addition, rising adoption of advanced wound dressing products is also one of the major factors responsible for regional growth.
Asia Pacific is anticipated to witness lucrative growth over the forecast period due to rise in disposable income, high unmet medical needs coupled with rapidly improving healthcare infrastructure and economic development in emerging countries such as China and India are some prime reasons for this rapid growth.
Growth Factors:
- Increasing demand for minimally invasive surgeries: Poloxamer 184 is used as a surfactant in many minimally invasive surgeries, owing to its ability to reduce surface tension and improve the flow of fluids. This is likely to drive the market growth in the coming years.
- Rising prevalence of chronic diseases: The global prevalence of chronic diseases such as cancer, diabetes, and heart disease is on the rise, which is expected to increase demand for Poloxamer 184-based products and therapies.
- Growing number of product approvals: The number of product approvals for Poloxamer 184 has been increasing over the past few years, owing to its various benefits such as reduced surgery time and improved patient outcomes. This is likely to boost market growth in the coming years.
- Technological advancements: Ongoing technological advancements are resulting in new applications for Poloxamer 184 across different industries, thereby driving market growth potentials. For instance, recent studies have shown that it can be used as a drug delivery vehicle for targeted drug delivery systems (TDDS). 5) Emerging markets offer significant growth potential: The globalPoloxamer184market offers significantgrowth potentialin emerging markets such as Chinaand India due tobetter healthcare infrastructureand rising awareness aboutthe benefitsof thissurfactant
Scope Of The Report
Report Attributes
Report Details
Report Title
Poloxamer 184 Market Research Report
By Type
Liquid, Liquid Gel
By Application
Dermatology, Human Pharmaceutical, Veterinary Health, Others
By Companies
Hannong Chemicals, BASF, Jiahua Chemicals, Comercial Química Massó, Croda
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
135
Number of Tables & Figures
95
Customization Available
Yes, the report can be customized as per your need.
Global Poloxamer 184 Market Report Segments:
The global Poloxamer 184 market is segmented on the basis of:
Types
Liquid, Liquid Gel
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Dermatology, Human Pharmaceutical, Veterinary Health, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Hannong Chemicals
- BASF
- Jiahua Chemicals
- Comercial Química Massó
- Croda
Highlights of The Poloxamer 184 Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Liquid
- Liquid Gel
- By Application:
- Dermatology
- Human Pharmaceutical
- Veterinary Health
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Poloxamer 184 Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Poloxamer 184 is a poloxamer. It is a type of surfactant that helps to reduce the surface tension of water, making it easier for liquids to mix.
Some of the key players operating in the poloxamer 184 market are Hannong Chemicals, BASF, Jiahua Chemicals, Comercial Qumica Mass³, Croda.
The poloxamer 184 market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Poloxamer 184 Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Poloxamer 184 Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Poloxamer 184 Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Poloxamer 184 Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Poloxamer 184 Market Size & Forecast, 2018-2028
4.5.1 Poloxamer 184 Market Size and Y-o-Y Growth
4.5.2 Poloxamer 184 Market Absolute $ Opportunity
Chapter 5 Global Poloxamer 184 Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Poloxamer 184 Market Size Forecast by Type
5.2.1 Liquid
5.2.2 Liquid Gel
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Poloxamer 184 Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Poloxamer 184 Market Size Forecast by Applications
6.2.1 Dermatology
6.2.2 Human Pharmaceutical
6.2.3 Veterinary Health
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Poloxamer 184 Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Poloxamer 184 Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Poloxamer 184 Analysis and Forecast
9.1 Introduction
9.2 North America Poloxamer 184 Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Poloxamer 184 Market Size Forecast by Type
9.6.1 Liquid
9.6.2 Liquid Gel
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Poloxamer 184 Market Size Forecast by Applications
9.10.1 Dermatology
9.10.2 Human Pharmaceutical
9.10.3 Veterinary Health
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Poloxamer 184 Analysis and Forecast
10.1 Introduction
10.2 Europe Poloxamer 184 Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Poloxamer 184 Market Size Forecast by Type
10.6.1 Liquid
10.6.2 Liquid Gel
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Poloxamer 184 Market Size Forecast by Applications
10.10.1 Dermatology
10.10.2 Human Pharmaceutical
10.10.3 Veterinary Health
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Poloxamer 184 Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Poloxamer 184 Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Poloxamer 184 Market Size Forecast by Type
11.6.1 Liquid
11.6.2 Liquid Gel
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Poloxamer 184 Market Size Forecast by Applications
11.10.1 Dermatology
11.10.2 Human Pharmaceutical
11.10.3 Veterinary Health
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Poloxamer 184 Analysis and Forecast
12.1 Introduction
12.2 Latin America Poloxamer 184 Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Poloxamer 184 Market Size Forecast by Type
12.6.1 Liquid
12.6.2 Liquid Gel
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Poloxamer 184 Market Size Forecast by Applications
12.10.1 Dermatology
12.10.2 Human Pharmaceutical
12.10.3 Veterinary Health
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Poloxamer 184 Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Poloxamer 184 Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Poloxamer 184 Market Size Forecast by Type
13.6.1 Liquid
13.6.2 Liquid Gel
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Poloxamer 184 Market Size Forecast by Applications
13.10.1 Dermatology
13.10.2 Human Pharmaceutical
13.10.3 Veterinary Health
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Poloxamer 184 Market: Competitive Dashboard
14.2 Global Poloxamer 184 Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Hannong Chemicals
14.3.2 BASF
14.3.3 Jiahua Chemicals
14.3.4 Comercial Química Massó
14.3.5 Croda
